Insider Transactions in Q1 2022 at Neu Base Therapeutics, Inc. (NBSE)
Insider Transaction List (Q1 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 30
2022
|
William Roland Mann Chief Operating Officer |
BUY
Open market or private purchase
|
Direct |
6,200
+35.63%
|
$6,200
$1.92 P/Share
|
|
Mar 18
2022
|
Todd P. Branning Chief Financial Officer |
BUY
Open market or private purchase
|
Direct |
10,000
+25.0%
|
$10,000
$1.81 P/Share
|
|
Mar 17
2022
|
Todd P. Branning Chief Financial Officer |
BUY
Open market or private purchase
|
Direct |
10,000
+33.33%
|
$10,000
$1.74 P/Share
|
|
Mar 16
2022
|
Todd P. Branning Chief Financial Officer |
BUY
Open market or private purchase
|
Direct |
10,000
+50.0%
|
$10,000
$1.62 P/Share
|
|
Mar 04
2022
|
Eric I Richman Director |
BUY
Open market or private purchase
|
Direct |
1,000
+2.18%
|
$1,000
$1.62 P/Share
|
|
Mar 03
2022
|
Eric I Richman Director |
BUY
Open market or private purchase
|
Direct |
1,300
+2.87%
|
$1,300
$1.72 P/Share
|
|
Mar 01
2022
|
Eric I Richman Director |
BUY
Open market or private purchase
|
Direct |
1,580
+3.57%
|
$1,580
$1.58 P/Share
|